Cargando…
晚期NSCLC维持治疗质疑与问题解析
Recently, several studies have been carried about maintenance therapy in non-small cell lung cancer, and some chemotherapy agents have been approved for clinical practice. But there are still a lot of questions about maintenance therapy that we have to consider. For example, the defects of design in...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000018/ https://www.ncbi.nlm.nih.gov/pubmed/24758902 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.02 |
Ejemplares similares
-
肺腺癌IASLC/ATS/ERS国际多学科分类以及临床实践中应注意的问题
Publicado: (2013) -
EGFR基因突变状态未知NSCLC治疗——TKI还是化疗?
Publicado: (2014) -
EGFR敏感突变的NSCLC脑转移患者治疗模式之争:临床到底该如何选择?
Publicado: (2020) -
加速康复外科:肺癌手术日间化现状与策略
Publicado: (2020) -
肿瘤患者新冠疫苗接种:临床研究进展与初步临床推荐
Publicado: (2021)